Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18617486 | SYSTEMS AND METHODS FOR ASSOCIATING COMPOUNDS WITH PROPERTIES USING CLIQUE ANALYSIS OF CELL-BASED DATA | March 2024 | March 2025 | Allow | 12 | 2 | 0 | No | No |
| 18519995 | COMPOSITIONS AND METHODS FOR EXPRESSING GENES OF INTEREST IN HOST CELLS | November 2023 | September 2024 | Allow | 10 | 2 | 1 | Yes | No |
| 18513348 | FUNCTION GUIDED IN SILICO PROTEIN DESIGN | November 2023 | August 2024 | Allow | 8 | 1 | 1 | Yes | No |
| 18509632 | SYSTEM AND METHOD FOR PREDICTING SUSCEPTIBILITY OF GENUS KLEBSIELLA TO AMIKACIN | November 2023 | June 2024 | Allow | 7 | 2 | 0 | No | No |
| 18479524 | METHODS AND SYSTEMS FOR USING DEEP LEARNING TO PREDICT PROTEIN-LIGAND COMPLEX STRUCTURES IN PROTEIN FOLDING AND PROTEIN-LIGAND CO-FOLDING | October 2023 | August 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18459180 | METHOD AND SYSTEM FOR PROVIDING GENETIC INFORMATION ANALYSIS RESULTS | August 2023 | June 2025 | Allow | 21 | 4 | 0 | Yes | No |
| 18453990 | METHYLATION-BASED FALSE POSITIVE DUPLICATE MARKING REDUCTION | August 2023 | January 2025 | Abandon | 17 | 1 | 0 | Yes | No |
| 18233738 | HOMELAND EXPLOSIVE CONSEQUENCE AND THREAT (HEXCAT) MODELING AND MEDICAL MITIGATION TOOL | August 2023 | October 2024 | Allow | 14 | 1 | 0 | No | No |
| 18335875 | SYSTEMS AND METHODS FOR PREDICTING RESULTS OF A MANUFACTURING PROCESS FOR GENERATING BIOLOGICAL STRUCTURES | June 2023 | July 2024 | Allow | 13 | 2 | 0 | Yes | No |
| 18329431 | SYSTEMS AND METHODS FOR EPIGENETIC ANALYSIS | June 2023 | March 2025 | Allow | 22 | 1 | 0 | No | No |
| 18324799 | SYSTEMS AND METHODS FOR ANALYZING VIRAL NUCLEIC ACIDS | May 2023 | August 2024 | Allow | 15 | 1 | 0 | No | No |
| 18316939 | SYSTEMS AND METHODS FOR GROUPING AND COLLAPSING SEQUENCING READS | May 2023 | June 2024 | Allow | 14 | 1 | 0 | No | No |
| 18312821 | METHOD FOR IMPROVING DISEASE DIAGNOSIS USING MEASURED ANALYTES | May 2023 | May 2025 | Abandon | 25 | 2 | 0 | No | No |
| 18132353 | SYSTEMS AND METHODS FOR MITOCHONDRIAL ANALYSIS | April 2023 | December 2024 | Abandon | 20 | 2 | 0 | No | No |
| 18188028 | METHOD FOR EVALUATING DISTRIBUTION OF INFECTED PERSONS IN AREA | March 2023 | February 2024 | Abandon | 11 | 1 | 0 | Yes | No |
| 18186747 | SYSTEM, METHOD, AND ARTICLE FOR DETECTING ABNORMAL CELLS USING MULTI-DIMENSIONAL ANALYSIS | March 2023 | July 2025 | Allow | 27 | 2 | 0 | No | No |
| 18043528 | IMPLEMENTING A GENERATIVE MACHINE LEARNING ARCHITECTURE TO PRODUCE TRAINING DATA FOR A CLASSIFICATION MODEL | February 2023 | April 2024 | Allow | 14 | 1 | 1 | Yes | No |
| 18095339 | SYSTEM AND METHOD FOR PROTEIN SELECTION | January 2023 | September 2023 | Allow | 8 | 2 | 0 | Yes | No |
| 18089319 | SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED BINDING SITE PREDICTION AND SEARCH SPACE FILTERING FOR BIOLOGICAL SCAFFOLD DESIGN | December 2022 | April 2024 | Allow | 16 | 1 | 1 | No | No |
| 18077016 | METHOD AND SYSTEM FOR ANALYZING SEQUENCES | December 2022 | July 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18075387 | SYSTEMS AND METHODS FOR INFERRING GENETIC ANCESTRY FROM LOW-COVERAGE GENOMIC DATA | December 2022 | February 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18070282 | SYSTEMS AND METHODS FOR GENE EXPRESSION ANALYSIS | November 2022 | May 2025 | Abandon | 30 | 2 | 1 | No | No |
| 17929836 | MASS SPECTROMETRIC IDENTIFICATION OF MICROORGANISMS IN COMPLEX SAMPLES | September 2022 | April 2024 | Abandon | 19 | 3 | 0 | Yes | No |
| 17901778 | ALIGNMENT FREE FILTERING FOR IDENTIFYING FUSIONS | September 2022 | November 2024 | Abandon | 26 | 2 | 0 | Yes | No |
| 17894669 | COMPUTATIONAL SYSTEMS AND METHODS FOR IMPROVING THE ACCURACY OF DRUG TOXICITY PREDICTIONS | August 2022 | December 2023 | Allow | 15 | 1 | 0 | No | No |
| 17821044 | Selection and Monitoring Methods for Xenotransplantation | August 2022 | November 2024 | Abandon | 26 | 2 | 0 | No | No |
| 17841536 | SYSTEMS AND METHODS FOR ASSOCIATING COMPOUNDS WITH PROPERTIES USING CLIQUE ANALYSIS OF CELL-BASED DATA | June 2022 | March 2024 | Allow | 21 | 3 | 0 | Yes | No |
| 17804963 | COMBINED PHYSIOLOGICAL SENSOR SYSTEMS AND METHODS | June 2022 | January 2025 | Allow | 31 | 3 | 0 | Yes | No |
| 17770000 | A UNIFIED PORTAL FOR REGULATORY AND SPLICING ELEMENTS FOR GENOME ANALYSIS | April 2022 | March 2025 | Abandon | 35 | 2 | 1 | Yes | No |
| 17670380 | SYSTEMS AND METHODS FOR DETECTING RECOMBINATION | February 2022 | March 2025 | Allow | 37 | 2 | 0 | No | No |
| 17668314 | CANCER DETECTION AND CLASSIFICATION USING METHYLOME ANALYSIS | February 2022 | January 2023 | Abandon | 11 | 1 | 0 | No | No |
| 17577078 | ASSESSMENT OF THE P13K CELLULAR SIGNALING PATHWAY ACTIVITY USING MATHEMATICAL MODELLING OF TARGET GENE EXPRESSION | January 2022 | March 2024 | Abandon | 26 | 1 | 0 | Yes | No |
| 17576471 | Homeland Explosive Consequence and Threat (HExCAT) Modeling Tool | January 2022 | May 2023 | Allow | 16 | 2 | 0 | Yes | No |
| 17553498 | MACHINE LEARNING TECHNIQUES FOR IDENTIFYING MALIGNANT B- AND T-CELL POPULATIONS | December 2021 | September 2023 | Abandon | 21 | 2 | 0 | No | No |
| 17531438 | Community Assignments in Identity by Descent Networks and Genetic Variant Origination | November 2021 | January 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17502339 | METHOD AND SYSTEM FOR PREDICTING RESPONSE TO IMMUNE ANTICANCER DRUGS | October 2021 | June 2025 | Allow | 44 | 2 | 0 | Yes | No |
| 17469600 | SURGICAL GUIDANCE AND PLANNING SOFTWARE FOR ASTIGMATISM TREATMENT | September 2021 | March 2024 | Abandon | 30 | 3 | 0 | Yes | No |
| 17415680 | A METHOD OF FINDING A TARGET ENVIRONMENT SUITABLE FOR GROWTH OF A PLANT VARIETY | June 2021 | May 2025 | Abandon | 47 | 0 | 1 | No | No |
| 17337786 | Selection and Monitoring Methods for Xenotransplantation | June 2021 | April 2022 | Allow | 10 | 2 | 0 | Yes | No |
| 17315335 | METHOD FOR ANALYSIS OF DRUG MOLECULAR DYNAMICS RESULTS BASED ON ROOT-MEAN-SQUARE DEVIATION MULTIPLE FEATURES | May 2021 | June 2022 | Abandon | 13 | 2 | 0 | Yes | No |
| 17307644 | METHOD FOR EVALUATING PANCREATIC CANCER, PANCREATIC CANCER EVALUATING APPARATUS, PANCREATIC CANCER EVALUATING METHOD, PANCREATIC CANCER EVALUATING PROGRAM PRODUCT, PANCREATIC CANCER EVALUATING SYSTEM AND INFORMATION COMMUNICATION TERMINAL APPARATUS | May 2021 | July 2024 | Allow | 38 | 2 | 0 | No | No |
| 17288053 | Heart Rate Detection Method, Heart Rate Detection Device and Program | April 2021 | July 2025 | Abandon | 50 | 2 | 0 | Yes | No |
| 17288113 | COLORED COIN HAVING INDIVIDUAL GENE PHENOTYPE APPLIED THERETO | April 2021 | April 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17221405 | DECODING APPROACHES FOR PROTEIN IDENTIFICATION | April 2021 | April 2023 | Abandon | 25 | 4 | 0 | Yes | No |
| 17281264 | AI-BASED CONDITION CLASSIFICATION SYSTEM FOR PATIENTS WITH NOVEL CORONAVIRUS | March 2021 | April 2025 | Allow | 48 | 1 | 0 | No | No |
| 17277514 | CHEMICAL COMPUTER | March 2021 | May 2025 | Allow | 50 | 2 | 0 | No | No |
| 17200281 | METHOD AND APPARATUS OF CHEMISTRY EDUCATION | March 2021 | February 2025 | Allow | 47 | 1 | 0 | Yes | No |
| 17047632 | Method and Device for Actuating an Analysis Device for Running an Analysis on a Sample Material | February 2021 | March 2025 | Abandon | 53 | 2 | 0 | No | No |
| 17180433 | EARLY LUNG CANCER DETECTION BY DNA METHYLATION PHENOTYPING OF SPUTUM-DERIVED CELLS | February 2021 | March 2023 | Allow | 25 | 1 | 0 | No | No |
| 17248083 | SYSTEMS AND METHODS FOR DETECTING HOMOPOLYMER INSERTIONS/DELETIONS | January 2021 | December 2024 | Abandon | 47 | 2 | 1 | No | No |
| 17126420 | METHOD AND APPARATUS OF PROVIDING OSTEOARTHRITIS PREDICTION INFORMATION | December 2020 | April 2025 | Abandon | 52 | 2 | 0 | No | No |
| 17113790 | LIVING BIOSENSORS | December 2020 | October 2024 | Allow | 47 | 4 | 1 | Yes | No |
| 15734527 | METHOD, APPARATUS, AND DEVICE FOR SIMULATING A TRAVEL PATH OF A CATHETER IN A BLOOD VESSEL | December 2020 | August 2024 | Allow | 44 | 2 | 0 | Yes | No |
| 17093571 | SYSTEM, METHOD, AND COMPUTER SOFTWARE PRODUCT FOR GENOTYPE DETERMINATION USING PROBE ARRAY DATA | November 2020 | December 2023 | Abandon | 37 | 1 | 0 | No | No |
| 17023289 | SYSTEMS AND METHODS FOR EPIGENETIC ANALYSIS | September 2020 | February 2023 | Allow | 29 | 1 | 0 | No | No |
| 16981431 | METHOD OF DIAGNOSING CELIAC DISEASE | September 2020 | October 2024 | Abandon | 49 | 1 | 0 | No | No |
| 17018629 | MULTICELLULAR METABOLIC MODELS AND METHODS | September 2020 | July 2023 | Abandon | 35 | 1 | 0 | No | No |
| 15733547 | A COMPUTER-IMPLEMENTED METHOD OF ANALYSING GENETIC DATA ABOUT AN ORGANISM | August 2020 | April 2025 | Allow | 56 | 2 | 0 | Yes | No |
| 16996792 | METHOD FOR IDENTIFYING AND QUANTIFYING POPULATIONS EXPOSED TO ENVIRONMENTAL HAZARDS ACROSS A GEOGRAPHIC REGION | August 2020 | May 2024 | Abandon | 44 | 2 | 1 | No | No |
| 16969072 | CT BIG DATA FROM SIMULATION, EMULATION AND TRANSFER LEARNING | August 2020 | August 2024 | Allow | 48 | 1 | 0 | No | No |
| 16987329 | DISCOVERY OF BIOLOGICAL SIGNATURES OF OPTIMIZED SENSITIVITY AND SPECIFICITY | August 2020 | June 2023 | Allow | 34 | 2 | 1 | Yes | No |
| 16965222 | COMPUTATIONAL GENERATION OF CHEMICAL SYNTHESIS ROUTES AND METHODS | July 2020 | December 2023 | Allow | 40 | 6 | 1 | Yes | No |
| 16937827 | SYSTEMS AND METHODS FOR ANALYZING VIRAL NUCLEIC ACIDS | July 2020 | February 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 16930213 | SYSTEM AND METHOD FOR RECOMMENDING PARAMETERS FOR A SURGICAL PROCEDURE | July 2020 | October 2024 | Abandon | 51 | 1 | 0 | No | No |
| 16918000 | PATHOGEN DISTRIBUTION INFORMATION PROVISION SYSTEM, PATHOGEN DISTRIBUTION INFORMATION PROVISION SERVER, AND METHOD FOR PROVIDING PATHOGEN DISTRIBUTION INFORMATION | July 2020 | March 2024 | Allow | 45 | 1 | 0 | Yes | No |
| 16771558 | PRE-SURGICAL RISK STRATIFICATION BASED ON PDE4D7 EXPRESSION AND PRE-SURGICAL CLINICAL VARIABLES | June 2020 | April 2024 | Allow | 46 | 1 | 1 | No | No |
| 16896877 | SYSTEMS, METHODS, AND APPARATUSES TO PREDICT PAIRS OF ENZYME PRIMARY SEQUENCES AND SUBSTRATES AND AN INTERACTION PROBABILITY FOR EACH PREDICTED PAIR | June 2020 | November 2023 | Allow | 41 | 1 | 1 | Yes | No |
| 16894028 | METHODS FOR PLACING, ACCEPTING, AND FILLING ORDERS FOR PRODUCTS AND SERVICES | June 2020 | March 2024 | Abandon | 46 | 1 | 0 | Yes | No |
| 16768042 | INCORPORATION OF FUSION GENES INTO PPI NETWORK TARGET SELECTION VIA GIBBS HOMOLOGY | May 2020 | June 2023 | Abandon | 37 | 1 | 0 | No | No |
| 16871833 | INTERLEUKIN-18 MIMICS AND METHODS OF USE | May 2020 | February 2024 | Allow | 45 | 1 | 1 | No | No |
| 16762371 | METHOD FOR SIMULTANEOUS MULTIVARIATE FEATURE SELECTION, FEATURE GENERATION, AND SAMPLE CLUSTERING | May 2020 | June 2024 | Abandon | 49 | 1 | 0 | No | No |
| 16865076 | SYSTEM, METHOD AND COMPUTER ACCESSIBLE-MEDIUM FOR MULTIPLEXING BASE CALLING AND/OR ALIGNMENT | May 2020 | March 2024 | Allow | 47 | 2 | 0 | Yes | No |
| 16859826 | High Throughput Patient Genomic Sequencing and Clinical Reporting Systems | April 2020 | April 2022 | Abandon | 23 | 2 | 0 | Yes | Yes |
| 16855535 | AUTOMATED PRIMING AND LIBRARY LOADING DEVICE | April 2020 | May 2023 | Abandon | 37 | 2 | 0 | Yes | No |
| 16841238 | GENERATION AND USE OF SIMULATED GENOMIC DATA | April 2020 | June 2024 | Allow | 50 | 1 | 0 | No | No |
| 16839469 | METHYLATION-BASED FALSE POSITIVE DUPLICATE MARKING REDUCTION | April 2020 | August 2023 | Allow | 40 | 1 | 0 | Yes | No |
| 16823195 | IMMUNO-ONCOLOGY APPLICATIONS USING NEXT GENERATION SEQUENCING | March 2020 | June 2025 | Abandon | 60 | 2 | 1 | No | Yes |
| 16809688 | BINDING STRUCTURE SEARCH APPARATUS, BINDING STRUCTURE SEARCH METHOD, AND COMPUTER-READABLE RECORDING MEDIUM | March 2020 | March 2024 | Abandon | 48 | 4 | 0 | No | No |
| 16798759 | SYSTEMS AND METHODS FOR MITOCHONDRIAL ANALYSIS | February 2020 | January 2023 | Allow | 34 | 1 | 0 | Yes | No |
| 16635996 | ALIGNMENT METHODS, DEVICES AND SYSTEMS | January 2020 | August 2022 | Allow | 30 | 4 | 0 | Yes | No |
| 16633809 | DESIGNED PROTEINS FOR LIGAND BINDING | January 2020 | April 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16746347 | METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING | January 2020 | September 2022 | Allow | 32 | 1 | 0 | Yes | No |
| 16740155 | Compositions and Methods for Analyzing Immobilized Nucleic Acids | January 2020 | March 2023 | Abandon | 38 | 2 | 0 | No | No |
| 16721060 | METHOD OF PROCESSING A SIGNAL REPRESENTING A PHYSIOLOGICAL RHYTHM | December 2019 | November 2023 | Abandon | 46 | 2 | 0 | No | No |
| 16713528 | METHOD FOR DETERMINING LYMPHOMA TYPE AND PROVIDING TREATMENT | December 2019 | December 2022 | Allow | 36 | 1 | 0 | No | No |
| 16705112 | SINGLE-MOLECULE OPTICAL SEQUENCE IDENTIFICATION OF NUCLEIC ACIDS AND AMINO ACIDS FOR COMBINED SINGLE-CELL OMICS AND BLOCK OPTICAL CONTENT SCORING (BOCS): DNA K-MER CONTENT AND SCORING FOR RAPID GENETIC BIOMARKER IDENTIFICATION AT LOW COVERAGE | December 2019 | September 2023 | Abandon | 46 | 1 | 1 | No | No |
| 16693954 | METHOD AND APPARATUS FOR REDUCING CHEMICAL REACTION MECHANISMS | November 2019 | July 2024 | Abandon | 55 | 4 | 0 | Yes | No |
| 16677646 | SINGLE MOLECULE-OVERLAPPING READ ANALYSIS FOR MINOR VARIANT MUTATION DETECTION IN PATHOGEN SAMPLES | November 2019 | April 2025 | Allow | 60 | 6 | 0 | Yes | No |
| 16676607 | OPTIMIZING K-MER DATABASES BY K-MER SUBTRACTION | November 2019 | August 2023 | Allow | 46 | 4 | 0 | Yes | No |
| 16667642 | SYSTEMS AND METHODS FOR GROUPING AND COLLAPSING SEQUENCING READS | October 2019 | February 2023 | Allow | 39 | 1 | 0 | Yes | No |
| 16664133 | METHOD AND APPARATUS FOR DETERMINING A SMOOTHED DATA POINT WITHIN A STREAM OF DATA POINTS | October 2019 | January 2023 | Allow | 39 | 1 | 0 | No | No |
| 16599969 | Computational Systems and Methods for Discovering Allosteric Sites and Allosteric Modulators of Proteins | October 2019 | November 2022 | Allow | 37 | 1 | 0 | Yes | No |
| 16598294 | MEDICAL INFORMATION PROCESSING SYSTEM AND MEDICAL INFORMATION PROCESSING METHOD | October 2019 | May 2025 | Allow | 60 | 4 | 1 | Yes | No |
| 16592070 | RATIONAL DESIGN OF MICROBIAL-BASED BIOTHERAPEUTICS | October 2019 | June 2023 | Allow | 45 | 2 | 1 | Yes | No |
| 16571855 | METHODS APPARATUSES AND SYSTEMS FOR DETECTING AND QUANTIFYING PHOSPHOPROTEINS | September 2019 | February 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16484167 | SYSTEMS, METHODS, AND APPARATUS FOR INDUCED PLURIPOTENT STEM CELL ISOLATION AND COMBINATORIAL PRODUCTION | August 2019 | April 2023 | Allow | 45 | 1 | 1 | Yes | No |
| 16534650 | DEVICE AND METHOD FOR SEARCHING COMPOUND | August 2019 | August 2023 | Allow | 49 | 3 | 0 | No | No |
| 16523674 | SYSTEMS AND METHODS FOR INFERRING GENETIC ANCESTRY FROM LOW-COVERAGE GENOMIC DATA | July 2019 | August 2022 | Allow | 36 | 1 | 0 | Yes | No |
| 16481061 | METHODS FOR BUILDING GENOMIC NETWORKS AND USES THEREOF | July 2019 | November 2023 | Allow | 51 | 2 | 0 | No | Yes |
| 16517778 | COMPUTER-BASED COMPUTATIONAL TOOLS FOR USE IN ELECTROPHYSIOLOGY | July 2019 | May 2022 | Allow | 34 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SKIBINSKY, ANNA.
With a 16.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SKIBINSKY, ANNA works in Art Unit 1635 and has examined 177 patent applications in our dataset. With an allowance rate of 62.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 45 months.
Examiner SKIBINSKY, ANNA's allowance rate of 62.1% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SKIBINSKY, ANNA receive 2.37 office actions before reaching final disposition. This places the examiner in the 81% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SKIBINSKY, ANNA is 45 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +23.1% benefit to allowance rate for applications examined by SKIBINSKY, ANNA. This interview benefit is in the 73% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 22.7% of applications are subsequently allowed. This success rate is in the 21% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 25.4% of cases where such amendments are filed. This entry rate is in the 26% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 46% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 42.9% of appeals filed. This is in the 6% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 42.6% are granted (fully or in part). This grant rate is in the 44% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 4.0% of allowed cases (in the 86% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.8% of allowed cases (in the 64% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.